US Drug Recall Register

FDA Drug Recalls

1,709 recalls · Class III, newest first

Class III · Low risk Ongoing

Tropicamide 1%

Reason Labeling: Label Mix-Up: The label of a dropper bottle mistakenly states the container is a 0.5mL single-use syringe instead of a 5 mL dropper

Fagron Compounding Services NDC 71266-8240-01 D-0125-2024
Class III · Low risk Terminated

LET Gel

Reason Product Mix-up: Incorrect Product Formulation

Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop NDC 73271-1003-1 D-0140-2024
Class III · Low risk Terminated

Hydrocortisone 1% and Acetic Acid 2% Otic Solution USP

Reason Failed Impurities/Degradation Specifications:Out-of-Specification result for Hydrocortisone related impurity and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.

Taro Pharmaceuticals Inc. NDC 51672-3007-1 D-0089-2024
Class III · Low risk Terminated

V-FORCE Homeopathic

Reason Incorrect Product Formulation: product contains Active Ingredient Glandula Suprarenalis Suis 8X instead of Glandula Suprarenalis Bovine 8X (as stated on the product label).

Grato Holdings, Inc. D-0099-2024
Class III · Low risk Terminated

Lisinopril Tablets USP 20 mg

Reason Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots

NCS Healthcare of Kentucky Inc NDC 0615-7718-05 D-0114-2024
Class III · Low risk Terminated

Buspirone Hydrochloride Tabs USP 10 mg

Reason Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots

NCS Healthcare of Kentucky Inc NDC 0615-7718-05 D-0113-2024
Class III · Low risk Terminated

Mycophenolate Mofetil for Oral Suspension

Reason Defective Container: The adaptor does not fit into the neck of the bottle after reconstitution with water.

VistaPharm LLC NDC 66689-307-08 D-0093-2024
Class III · Low risk Terminated

Esomeprazole Magnesium Delayed-Release Capsules

Reason Failed Impurities/Degradation Specifications:Out of Specification result reported for the test of organic impurities for the drug product,at the 18 month time point in long term stability study (25¿C/60% RH).

Glenmark Pharmaceuticals Inc., USA NDC 68462-390-30 D-0112-2024
Class III · Low risk Ongoing

Oxaydo

Reason Sub-potent Drug: Lower potency than labeled.

Zyla Life Sciences US Inc. D-0094-2024
Class III · Low risk Terminated

Opium Tincture

Reason Subpotent Drug

Edenbridge Pharmaceuticals, LLC NDC 42799-217-01 D-0080-2024
Class III · Low risk Terminated

Aminocaproic Acid Oral Solution

Reason Failed Excipient Specifications: high content of ethylene glycol (EG)

VistaPharm LLC NDC 66689-330-08 D-0126-2024
Class III · Low risk Ongoing

Synthroid

Reason Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.

AbbVie Inc. NDC 0074-7068-11 D-0088-2024
Class III · Low risk Terminated

VANCOmycin HCI PF

Reason Labeling: Not Elsewhere Classified

Denver Solutions, LLC DBA Leiters Health NDC 71449-029-68 D-0072-2024
Class III · Low risk Terminated

VANCOmycin HCI PF

Reason Labeling: Not Elsewhere Classified

Denver Solutions, LLC DBA Leiters Health NDC 71449-028-68 D-0071-2024
Class III · Low risk Terminated

Oxytocin synthetic

Reason Labeling: Not Elsewhere Classified

Denver Solutions, LLC DBA Leiters Health NDC 71449-157-70 D-0070-2024
Class III · Low risk Terminated

Epinephrine-Lidocaine HCl

Reason Subpotent: Failing Test Results for Epinephrine

Imprimis NJOF, LLC NDC 71384-640-01 D-0040-2024
Class III · Low risk Ongoing

Methotrexate Tablets

Reason Failed Tablet/Capsule Specifications: Tablets were observed to have an unsmooth surface with two tablets demonstrating illegible tablet identification and scoring.

West-Ward Columbus Inc D-0066-2024
Class III · Low risk Terminated

Eligard

Reason Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product.

Tolmar, Inc. NDC 62935-753-75 D-1178-2023
Class III · Low risk Terminated

Cequa

Reason Subpotent: Out of Specification result observed for low assay

Sun Pharmaceutical Industries INC NDC 47335-506-96 D-1172-2023
Class III · Low risk Terminated

HydrALAZINE Hydrochloride Tablets

Reason Failed Impurities/Degradation Specifications: Out of Specification results in the repackaged product for impurities at the 12-month time point.

Amerisource Health Services LLC D-0039-2024
Class III · Low risk Terminated

Clearasil Rapid Rescue Deep Treatment Pads

Reason Labeling: Label Error on Declared Strength: The incorrect label on the back of the product packaging.

RB Health (US) LLC NDC 63824-431-90 D-1179-2023